January 11, 2021 Sanofi makes a pre-JP Morgan splash with Kymab The Kymab takeover represents another bold move as the French company bids to rebuild its pipeline.
February 06, 2019 Glaxo adds flesh to its oncology ambitions As Glaxosmithkline manoeuvres to become a major player in cancer, it backs Icos among other novel mechanisms.